Capital Wealth Alliance’s Gossamer Bio GOSS Stock Holding History

Capital Wealth Alliance’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-300	Closed	-$4K	–	187
2019 Q4	$4K	Buy	+300	New	+$6.04K	﹤0.01%	262

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Wealth Alliance's GOSS Position: Q1 2020 in Review

Capital Wealth Alliance sold out of Gossamer Bio (GOSS) in Q1 2020, closing a stake of 300 shares — an estimated $4K sold.

Capital Wealth Alliance first reported a position in GOSS in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 96 funds tracked by Wall St. Rank hold GOSS as of Q1 2020.

Capital Wealth Alliance reported no remaining Gossamer Bio position as of Q1 2020 after selling out during the quarter.
Capital Wealth Alliance sold 300 Gossamer Bio shares in Q1 2020, an estimated $4K.
Capital Wealth Alliance first reported a position in Gossamer Bio in Q4 2019 and held it in 1 quarter.
Capital Wealth Alliance's Gossamer Bio position peaked at $4K in Q4 2019.
96 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.